Global Dermatological Drugs market to grow to $39bn by 2025

Thursday 5 December 2019, Amsterdam

Market Research Report Press Release Dermatological Drugs Market Forecast 2020-2030: Psoriasis, Skin Infection, Acne, Dermatitis, Others.

The dermatological drugs market is a specialist segment of the pharmaceutical market which over the last several years has been growing at a faster rate than the overall market. This has been due partly to the high growth potential of biological treatments for psoriasis. The development of new antibacterial drugs to address the problems of population ageing and drug-resistant strains of bacteria will also contribute to the overall market growth. In other segments, high generic penetration and intense competition limit profitability.

The lead analyst of the report commented "The prevention and treatment of dermatological conditions is becoming a priority for many healthcare authorities worldwide. The increasing incidence of skin and skin structure infections (SSSI) acquired in hospitals and the community is being exacerbated by resistance to existing antibacterial therapies.

Moreover, the ageing immunocompromised population will drive the increasing prevalence of skin and skin structure infections. Throughout the forecast period, we expect global demand for dermatological drugs to increase significantly. This trend will be driven by the expansion in emerging markets, where expansion in healthcare provision will increase demand. Economic growth and the expansion of the middle class in these emerging markets will further drive the demand for dermatological treatments."

Leading companies featured in the report include AbbVie, Allergan, Amgen, Bausch Health, Bayer AG, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly, Galderma (Nestle Skin Health S.A.), GlaxoSmithKline (GSK) and other companies.
Dermatological Drugs Market Forecast 2020-2030

Dermatological Drugs Market Forecast 2020-2030

Publish date : October 2019
Report code : ASDR-497243
Pages : 355

ASDReports.com Media contact: S. Koopman - Marketing and Communications

ASDReports.com / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216 - E : stefan.koopman@asdreports.com

 back to News